Recipharm

Activities: Manufacturing Ingredients Drug Delivery Research & Development Pharmaceutical

Trending Articles

  1. Enhancing solubility with novel excipients With the growing prevalence of complex drug molecules, formulation is becoming ever more challenging. Novel excipients can unlock their potential, says Meera Raghuram, Director...
  2. SGS achieves breakthrough in infectious disease research with launch of novel RSV A-strain Derived from a 2015 circulating strain, SGS's novel RSV-A challenge agent offers a closer match to circulating RSV viruses than strains currently used in clinical research
  3. Poolbeg Pharma trial to feature in groundbreaking cancer immunotherapy-induced CRS research programme Poolbeg will act as the lead business partner, alongside Johnson & Johnson and other partners, on the University of Manchester and The Christie NHS Foundation Trust research...
  4. Buckland Group launches Quvara Medical after acquiring Becton Dickinson’s Swindon site to boost UK-EU medical manufacturing The acquisition establishes Quvara Medical as a new UK- and EU-based CMO offering GMP- and ISO-certified, high-volume manufacturing services to pharma and medtech clients
  5. SeaBeLife partners with Unither Pharmaceuticals for ophthalmic drug production The new partnership aims to produce clinical and commercial batches of ophthalmic formulation of SeaBeLife’s drug candidate SBL03 to treat degenerative disorders of the...

Upcoming event

From powder to granules: a deep dive into wet granulation methods

14 January 2026 | Virtual See all

Related Content

Manufacturing

RecBioPharm to deal with fill-finish for Oxford Uni's malaria vaccine candidates

The biologics CDMO will be responsible for large-scale fill/finish activities, as well as drug substance and product manufacturing
Manufacturing

Recipharm and ProductLife Group join forces to accelerate biologic development projects

The companies will provide customers with integrated development, manufacturing, regulatory and market expertise for an end-to-end service
You need to be a subscriber to read this article.
Click here to find out more.
Distribution

DCAT preview: the future of pharma manufacturing

Ahead of the upcoming trade show, Dr Kevin Robinson caught up with pharmaceutical industry experts to discuss how they’re innovating for resilience and sustainability in 2025 and beyond
Manufacturing

Recipharm expands aseptic filling capabilities at Wasserburg, Germany site

The novel system facilitates the cost-effective, GMP-compliant aseptic manufacture of PFSs, syringes and vials at a small scale, delivering between 500 to 50,000 units per batch
Manufacturing

ReciBioPharm attains Bill & Melinda Gates Foundation grant to achieve continuous RNA manufacturing

The biologics CDMO hopes to bring RNA medicines to more patients globally by providing its xRNA continuous manufacturing technology to lower and middle income countries
Manufacturing

Recipharm expands oral solid development and pilot scaling capabilities at Zwickau site

The CDMO's facility now has a range of pilot-scale OSD manufacturing capabilities, such as blending, hard capsule filling and tableting
Manufacturing

ReciBioPharm partners with Hongene Biotech to provide sgRNA manufacturing capabilities

ReciBioPharm will now offer sgRNA manufacturing capabilities on top of its current mRNA, LNP and fill-finish services
Subscribe now